The National Institute of Allergy and Infectious Diseases (NIAID), which is part of the NIH, received $400 million from Moderna in a “catch-up payment,” according to a newly disclosed contract that The Epoch Times obtained through a Freedom of Information Act request.
So where is the money going? Which government officials are getting the money?
Kash Patel argues that it poses a major conflict of interest for scientists at the NIH to be able to receive royalties from patents.
“Do people in the Department of Agriculture who work with private-sector farmers and come up with some new seed receive millions of dollars from the farming industry? No,” Patel said.
“What about the army guy that comes up with the technology for our next aerial asset, [and] we enter into a contract with Lockheed Martin or Boeing to make billions of dollars worth of this? Is he going to get a royalty from that? Absolutely not,” he said.
The NIH received up to $2 billion in royalties from 34 drug contracts between 1991 and 2019, according to a report from the U.S. Government Accountability Office.
We also take a look at new allegations of bribery in FTX founder Sam Bankman-Fried’s case. On top of the 12 counts he was already indicted on, he’s now being charged for allegedly bribing Chinese officials to the tune of over $40 million to get his accounts in China unfrozen.